FIP_BPS
@fip_bps
FIP’s Board of Pharmaceutical Sciences sharing the latest news and views with scientists around the world.
ID: 1124323103243419648
https://www.fip.org/pharmaceutical-sciences-and-the-special-interest-groups-sigs 03-05-2019 14:41:31
770 Tweet
758 Followers
37 Following
A blood-first assay screening trial found entrectinib equally effective in advanced/metastatic non-small cell lung cancer patients diagnosed by liquid biopsy or tissue testing, achieving an 81.5% response rate. More in Nature Medicine: nature.com/articles/s4159…